A detailed history of Clari Vest Asset Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 1,317 shares of AMRX stock, worth $10,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,317
Previous 1,317 -0.0%
Holding current value
$10,246
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$5.36 - $7.11 $2,406 - $3,192
449 Added 51.73%
1,317 $8,000
Q1 2024

May 06, 2024

BUY
$5.24 - $6.34 $707 - $855
135 Added 18.42%
868 $5,000
Q4 2023

Feb 13, 2024

BUY
$3.36 - $6.21 $537 - $993
160 Added 27.92%
733 $4,000
Q3 2023

Nov 13, 2023

BUY
$2.76 - $4.59 $516 - $858
187 Added 48.45%
573 $2,000
Q1 2023

May 08, 2023

SELL
$1.27 - $2.7 $123,728 - $263,044
-97,424 Reduced 99.61%
386 $1,000
Q4 2022

Feb 14, 2023

SELL
$1.96 - $2.61 $313 - $417
-160 Reduced 0.16%
97,810 $194,000
Q3 2022

Nov 10, 2022

SELL
$2.02 - $3.62 $537 - $962
-266 Reduced 0.27%
97,970 $198,000
Q2 2022

Aug 12, 2022

SELL
$3.01 - $4.46 $148,338 - $219,797
-49,282 Reduced 33.41%
98,236 $312,000
Q1 2022

May 04, 2022

BUY
$3.9 - $4.89 $132,908 - $166,646
34,079 Added 30.04%
147,518 $616,000
Q4 2021

Feb 14, 2022

SELL
$3.95 - $5.85 $15,073 - $22,323
-3,816 Reduced 3.25%
113,439 $543,000
Q3 2021

Nov 08, 2021

SELL
$4.31 - $5.64 $12,615 - $16,508
-2,927 Reduced 2.44%
117,255 $626,000
Q2 2021

Aug 09, 2021

BUY
$5.12 - $6.82 $829 - $1,104
162 Added 0.13%
120,182 $614,000
Q1 2021

May 13, 2021

BUY
$4.74 - $7.38 $563,405 - $877,201
118,862 Added 10264.42%
120,020 $808,000
Q2 2020

Aug 12, 2020

BUY
$2.87 - $5.46 $3,323 - $6,322
1,158 New
1,158 $6,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.18B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.